IND Investigator Responsibilities Performance of FDA-regulated studies using investigational drugs or biologics (i.e., agents that require an IND application/number for human use) creates important ...

announced today that the U.S. Food and Drug Administration (FDA) cleared its Investigational New Drug (IND) application for TYRA-300 allowing the company to proceed with a Phase 2 clinical trial ...

For more information on the trial, visit the study page on ClinicalTrials.gov. "The FDA's IND clearance is a pivotal moment for Accent Therapeutics, propelling our lead program into the clinical ...

CERo Therapeutics (CERO) announces that the U.S. Food and Drug Administration has cleared the Company’s Investigational New Drug Application for Phase 1 clinical trials of its lead compound ...

Company to conduct a Phase 1 Drug-Drug Interaction Study Phase 2 filing on track for Q1 2025 The DDI study is designed to evaluate the effect of a cytochrome P450 inhibitor and inducer on ALG ...